Author

Stephen Forrow

Institute for Research in Biomedicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Alex BoussioutasiD· 1 shared Amr H. AllamiD· 1 shared Anna Pons-GrífolsiD· 1 shared Anne Huber· 1 shared Ashleigh R. PohiD· 1 shared Barbara Tondelli· 1 shared Benjamin TrinitéiD· 1 shared Bonaventura ClotetiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex BoussioutasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Anna Pons-Grífols, Ferran Tarrés-Freixas, Mónica Pérez, Eva Riveira‐Muñoz, Dàlia Raïch Regué, Daniel Perez‐Zsolt, Jordana Muñoz‐Basagoiti, Barbara Tondelli, Edwards Pradenas, Nuria Izquierdo‐Useros, Sara Capdevila, Júlia Vergara‐Alert, Víctor Urrea, Jorge Carrillo, Ester Ballana, , Julià Blanco

This paper introduces a knock-in mouse model for SARS-CoV-2 infection that replicates respiratory issues but avoids neurological disease seen in the K18-hACE2 model.

mBio · Apr 24, 2025Peer-reviewedMicrobiology

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within Interleukin-6 family cytokines

Anne Huber, Amr H. Allam, Christine Dijkstra, Stefan Thiem, Jennifer Huynh, Ashleigh R. Poh, Joshua Konecnik, Saumya P. Jacob, Rita A. Busuttil, Yang Liao, David Chisanga, Wei Shi, Mariah Alorro, Stephen Forrow, Daniele V. F. Tauriello, , Moritz F. Eissmann

This study identifies IL6/STAT3 signaling as a therapeutic target for TP53-mutant gastric cancer by showing its role in metastatic progression driven by mutant Trp53.

Cell Reports · Aug 1, 2024Peer-reviewedCancer Biology